Pimilprost
Alternative Names: Skipron; SM 10902Latest Information Update: 29 Jan 2008
At a glance
- Originator Dainippon Sumitomo Pharma
- Class Antiplatelets; Peripheral vasodilators; Prostaglandins; Small molecules
- Mechanism of Action Epoprostenol agonists; Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Skin ulcer
Most Recent Events
- 01 Oct 2005 Sumitomo Pharmaceuticals has merged with Dainippon Pharmaceutical to form Dainippon Sumitomo Pharma
- 31 Jul 1998 Preregistration for Decubitus ulcer in Japan (Unknown route)
- 31 Jul 1998 Preregistration for Peripheral vascular disorders in Japan (Unknown route)